Showing posts with label Dr. Ross Cranston. Show all posts
Showing posts with label Dr. Ross Cranston. Show all posts

Tuesday, March 6, 2012

Join IRMA for an Upcoming FREE Global Teleconference on the Latest in Rectal Microbicide Research

Rectal Microbicide Research Update - MTN 007 and MTN 017

There are exciting new developments in the rectal microbicide field. Please join IRMA and AVAC for a FREE global teleconference Thursday, March 15, 10am eastern, featuring Drs. Ian McGowan and Ross Cranston of the Microbicide Trials Network (MTN). Ian (co-principal investigator of the MTN) will share results from the MTN 007 trial - just released at CROI 2012.

Following Ian, Ross will discuss the upcoming MTN 017 trial - a Phase II safety and acceptability trial of the same gel studied in MTN 007 - which will have sites in 4 countries and will start later this year. MTN 017 is the first Phase II trial to be conducted in the rectal microbicide field, and will be the first time that trial sites from outside the U.S. are included.

Click here for more info on the call and to register.

For more info on MTN 007, click here.

For more info on MTN 017, click here.

Tuesday, March 1, 2011

Pittsburgh's Dynamic Rectal Duo

IRMA Scientific Vice Chair Ian McGowan and his research/life partner, Ross Cranston (also a member of the IRMA Steering Committee) are featured in CUE Pittsburgh this month. They talk about our favorite topic - rectal microbicides - and a trial taking place right in Pittsburgh that gay men can get involved in.

The article, below, starts on Page 17. Use the arrows on both sides of the magazine to "flip" pages forward and back.






[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]
Related Posts Plugin for WordPress, Blogger...